These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33816277)

  • 1. CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer.
    Kumamoto K; Tasaki T; Ohnishi K; Shibata M; Shimajiri S; Harada M; Komohara Y; Nakayama T
    Front Oncol; 2021; 11():636751. PubMed ID: 33816277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High CD169 expression in lymph node macrophages predicts a favorable clinical course in patients with esophageal cancer.
    Takeya H; Shiota T; Yagi T; Ohnishi K; Baba Y; Miyasato Y; Kiyozumi Y; Yoshida N; Takeya M; Baba H; Komohara Y
    Pathol Int; 2018 Dec; 68(12):685-693. PubMed ID: 30516869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer.
    Shiota T; Miyasato Y; Ohnishi K; Yamamoto-Ibusuki M; Yamamoto Y; Iwase H; Takeya M; Komohara Y
    PLoS One; 2016; 11(11):e0166680. PubMed ID: 27861544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of CD169-positive lymph node sinus macrophages in patients with endometrial carcinoma.
    Ohnishi K; Yamaguchi M; Erdenebaatar C; Saito F; Tashiro H; Katabuchi H; Takeya M; Komohara Y
    Cancer Sci; 2016 Jun; 107(6):846-52. PubMed ID: 26991548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.
    Asano T; Ohnishi K; Shiota T; Motoshima T; Sugiyama Y; Yatsuda J; Kamba T; Ishizaka K; Komohara Y
    Cancer Sci; 2018 May; 109(5):1723-1730. PubMed ID: 29520898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin potentiates anti-tumor immunity against oral cancer by inducing lymph node CD169-positive macrophage activation and cytotoxic T cell infiltration.
    Kawaguchi S; Kawahara K; Fujiwara Y; Ohnishi K; Pan C; Yano H; Hirosue A; Nagata M; Hirayama M; Sakata J; Nakashima H; Arita H; Yamana K; Gohara S; Nagao Y; Maeshiro M; Iwamoto A; Hirayama M; Yoshida R; Komohara Y; Nakayama H
    Cancer Immunol Immunother; 2022 Sep; 71(9):2127-2139. PubMed ID: 35044489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD169-positive macrophages in regional lymph nodes are associated with a favorable prognosis in patients with colorectal carcinoma.
    Ohnishi K; Komohara Y; Saito Y; Miyamoto Y; Watanabe M; Baba H; Takeya M
    Cancer Sci; 2013 Sep; 104(9):1237-44. PubMed ID: 23734742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural compounds that regulate lymph node sinus macrophages: Inducing an anti-tumor effect by regulating macrophage activation.
    Fujiwara Y; Saito Y; Shiota T; Cheng P; Ikeda T; Ohnishi K; Takeya M; Komohara Y
    J Clin Exp Hematop; 2018; 58(1):17-23. PubMed ID: 29553092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible functions of CD169-positive sinus macrophages in lymph nodes in anti-tumor immune responses.
    Komohara Y; Ohnishi K; Takeya M
    Cancer Sci; 2017 Mar; 108(3):290-295. PubMed ID: 28002629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of CD169+ Lymph Node Sinus Macrophages in Patients with Malignant Melanoma.
    Saito Y; Ohnishi K; Miyashita A; Nakahara S; Fujiwara Y; Horlad H; Motoshima T; Fukushima S; Jinnin M; Ihn H; Takeya M; Komohara Y
    Cancer Immunol Res; 2015 Dec; 3(12):1356-63. PubMed ID: 26297710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD169 identifies an activated CD8(+) T cell subset in regional lymph nodes that predicts favorable prognosis in colorectal cancer patients.
    Zhang J; Xu J; Zhang RX; Zhang Y; Ou QJ; Li JQ; Jiang ZZ; Wu XJ; Fang YJ; Zheng L
    Oncoimmunology; 2016 Jul; 5(7):e1177690. PubMed ID: 27622027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD169 Expression in Lymph Nodes is Associated with Increased Infiltration of CD8
    Wang Y; Wu XT; Chen J
    J Immunol Res; 2024; 2024():8873767. PubMed ID: 38250298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-localization of CD169
    Björk Gunnarsdottir F; Auoja N; Bendahl PO; Rydén L; Fernö M; Leandersson K
    Oncoimmunology; 2020 Nov; 9(1):1848067. PubMed ID: 33299660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced number of CD169
    Strömvall K; Sundkvist K; Ljungberg B; Halin Bergström S; Bergh A
    Prostate; 2017 Nov; 77(15):1468-1477. PubMed ID: 28880401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-patient spatial comparison of non-metastatic and metastatic lymph nodes reveals the reduction of CD169
    Maeshima Y; Kataoka TR; Vandenbon A; Hirata M; Takeuchi Y; Suzuki Y; Fukui Y; Kawashima M; Takada M; Ibi Y; Haga H; Morita S; Toi M; Kawaoka S; Kawaguchi K
    EBioMedicine; 2024 Sep; 107():105271. PubMed ID: 39173531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maf expression in human macrophages and lymph node sinus macrophages in patients with esophageal cancer.
    Takeya H; Ohnishi K; Shiota T; Saito Y; Fujiwara Y; Yagi T; Kiyozumi Y; Baba Y; Yoshida N; Asano K; Tanaka M; Baba H; Komohara Y
    J Clin Exp Hematop; 2019; 59(3):112-118. PubMed ID: 31564713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference between sentinel and non-sentinel lymph nodes in the distribution of dendritic cells and macrophages: An immunohistochemical and morphometric study using gastric regional nodes obtained in sentinel node navigation surgery for early gastric cancer.
    Sonoda T; Arigami T; Aoki M; Matsushita D; Shimonosono M; Tsuruda Y; Sasaki K; Ohtsuka T; Murakami G
    J Anat; 2024 Oct; ():. PubMed ID: 39367691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD169 identifies an anti-tumour macrophage subpopulation in human hepatocellular carcinoma.
    Zhang Y; Li JQ; Jiang ZZ; Li L; Wu Y; Zheng L
    J Pathol; 2016 Jun; 239(2):231-41. PubMed ID: 27174787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Protein and Peptide Targeting for the Development of a CD169-Based Vaccination Strategy Against Melanoma.
    van Dinther D; Veninga H; Revet M; Hoogterp L; Olesek K; Grabowska J; Borg EGF; Kalay H; van Kooyk Y; den Haan JMM
    Front Immunol; 2018; 9():1997. PubMed ID: 30237798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD169
    Nagata M; Ishizaka K; Asano T
    Res Rep Urol; 2023; 15():1-7. PubMed ID: 36660299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.